Thermo Fisher Scientific EBITDA Margin 2010-2024 | TMO
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Thermo Fisher Scientific (TMO) over the last 10 years. The current EBITDA margin for Thermo Fisher Scientific as of December 31, 2024 is .
| Thermo Fisher Scientific EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-12-31 | $42.88B | $10.45B | 24.36% |
| 2024-09-30 | $42.37B | $10.38B | 24.50% |
| 2024-06-30 | $42.35B | $10.52B | 24.84% |
| 2024-03-31 | $42.49B | $10.34B | 24.34% |
| 2023-12-31 | $42.86B | $10.27B | 23.95% |
| 2023-09-30 | $43.42B | $10.28B | 23.68% |
| 2023-06-30 | $43.52B | $10.11B | 23.23% |
| 2023-03-31 | $43.81B | $10.52B | 24.01% |
| 2022-12-31 | $44.92B | $11.77B | 26.21% |
| 2022-09-30 | $44.17B | $12.29B | 27.82% |
| 2022-06-30 | $42.82B | $12.64B | 29.53% |
| 2022-03-31 | $41.12B | $12.63B | 30.71% |
| 2021-12-31 | $39.21B | $12.62B | 32.18% |
| 2021-09-30 | $39.06B | $13.07B | 33.47% |
| 2021-06-30 | $38.25B | $13.17B | 34.42% |
| 2021-03-31 | $35.89B | $12.31B | 34.29% |
| 2020-12-31 | $32.22B | $10.12B | 31.41% |
| 2020-09-30 | $28.50B | $8.25B | 28.96% |
| 2020-06-30 | $26.25B | $6.77B | 25.81% |
| 2020-03-31 | $25.65B | $6.88B | 26.81% |
| 2019-12-31 | $25.54B | $6.87B | 26.90% |
| 2019-09-30 | $25.22B | $6.77B | 26.84% |
| 2019-06-30 | $24.87B | $6.72B | 27.03% |
| 2019-03-31 | $24.63B | $6.16B | 25.03% |
| 2018-12-31 | $24.36B | $6.05B | 24.84% |
| 2018-09-30 | $23.90B | $5.88B | 24.58% |
| 2018-06-30 | $23.09B | $5.55B | 24.04% |
| 2018-03-31 | $22.01B | $5.27B | 23.94% |
| 2017-12-31 | $20.92B | $4.99B | 23.87% |
| 2017-09-30 | $19.82B | $4.70B | 23.69% |
| 2017-06-30 | $19.20B | $4.52B | 23.54% |
| 2017-03-31 | $18.74B | $4.37B | 23.30% |
| 2016-12-31 | $18.27B | $4.22B | 23.07% |
| 2016-09-30 | $17.97B | $4.10B | 22.78% |
| 2016-06-30 | $17.61B | $4.11B | 23.36% |
| 2016-03-31 | $17.34B | $4.06B | 23.38% |
| 2015-12-31 | $16.97B | $4.03B | 23.73% |
| 2015-09-30 | $16.81B | $3.98B | 23.68% |
| 2015-06-30 | $16.85B | $4.08B | 24.23% |
| 2015-03-31 | $16.91B | $3.85B | 22.78% |
| 2014-12-31 | $16.89B | $4.19B | 24.80% |
| 2014-09-30 | $15.86B | $3.82B | 24.10% |
| 2014-06-30 | $14.89B | $3.37B | 22.65% |
| 2014-03-31 | $13.80B | $3.21B | 23.28% |
| 2013-12-31 | $13.09B | $2.61B | 19.94% |
| 2013-09-30 | $12.88B | $2.56B | 19.88% |
| 2013-06-30 | $12.78B | $2.52B | 19.68% |
| 2013-03-31 | $12.65B | $2.50B | 19.76% |
| 2012-12-31 | $12.51B | $2.47B | 19.70% |
| 2012-09-30 | $12.30B | $2.40B | 19.54% |
| 2012-06-30 | $12.15B | $2.35B | 19.36% |
| 2012-03-31 | $11.90B | $2.21B | 18.57% |
| 2011-12-31 | $11.56B | $2.11B | 18.26% |
| 2011-09-30 | $11.05B | $2.00B | 18.08% |
| 2011-06-30 | $10.75B | $1.94B | 18.03% |
| 2011-03-31 | $10.49B | $1.96B | 18.64% |
| 2010-12-31 | $10.39B | $1.93B | 18.54% |
| 2010-09-30 | $10.49B | $1.91B | 18.16% |
| 2010-06-30 | $10.40B | $1.89B | 18.20% |
| 2010-03-31 | $10.28B | $1.86B | 18.11% |
| 2009-12-31 | $9.91B | $1.76B | 17.80% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $187.725B | $42.879B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $176.405B | 80.93 |
| Alcon (ALC) | Switzerland | $46.824B | 31.12 |
| Edwards Lifesciences (EW) | United States | $42.608B | 27.66 |
| IDEXX Laboratories (IDXX) | United States | $34.032B | 39.36 |
| IQVIA Holdings (IQV) | United States | $31.084B | 17.20 |
| DexCom (DXCM) | United States | $26.777B | 41.39 |
| Mettler-Toledo (MTD) | United States | $24.611B | 28.69 |
| STERIS (STE) | Ireland | $22.269B | 25.47 |
| Waters (WAT) | United States | $21.897B | 31.05 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.380B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.612B | 14.91 |
| Hologic (HOLX) | United States | $13.861B | 14.96 |
| Sysmex ADR (SSMXY) | Japan | $11.941B | 37.44 |
| Penumbra (PEN) | United States | $10.300B | 93.17 |
| Globus Medical (GMED) | United States | $10.068B | 23.31 |
| Masimo (MASI) | United States | $9.002B | 37.78 |
| Teleflex (TFX) | United States | $6.407B | 9.86 |
| Glaukos (GKOS) | United States | $5.567B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.967B | 22.27 |
| PROCEPT BioRobotics (PRCT) | United States | $3.194B | 0.00 |
| Veracyte (VCYT) | United States | $2.311B | 41.76 |
| TransMedics (TMDX) | United States | $2.265B | 66.61 |
| Nihon Kohden (NHNKY) | Japan | $2.205B | 12.06 |
| LivaNova (LIVN) | United Kingdom | $2.135B | 12.96 |
| Elekta AB (EKTAY) | Sweden | $1.995B | 17.93 |
| Integra LifeSciences Holdings (IART) | United States | $1.698B | 8.59 |
| Alphatec Holdings (ATEC) | United States | $1.462B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.274B | 0.00 |
| OPKO Health (OPK) | United States | $1.115B | 0.00 |
| Paragon 28 (FNA) | United States | $1.096B | 0.00 |
| Artivion (AORT) | United States | $1.034B | 98.32 |
| RxSight (RXST) | United States | $1.022B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| AxoGen (AXGN) | United States | $0.820B | 0.00 |
| IRadimed (IRMD) | United States | $0.667B | 34.99 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 10.61 |
| Mesa Laboratories (MLAB) | United States | $0.645B | 14.09 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.636B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.598B | 0.00 |
| SiBone (SIBN) | United States | $0.596B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.531B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.525B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.425B | 0.00 |
| NeuroPace (NPCE) | United States | $0.400B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.380B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.351B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.347B | 7.37 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| CVRx (CVRX) | United States | $0.318B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.313B | 16.73 |
| Nevro (NVRO) | United States | $0.224B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Accuray (ARAY) | United States | $0.184B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.177B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| 908 Devices (MASS) | United States | $0.158B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.123B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.117B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.114B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 11.82 |
| EDAP TMS S.A (EDAP) | France | $0.073B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.052B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.027B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |